‘One-Stop’ Bloodstream Test for Cancer Shows Early Promise

 

Korean researchers develop a method of detecting cancer through blood test

Video taken from the channel: ARIRANG NEWS


 

Blood test for early cancer detection shows promising results

Video taken from the channel: CBC News


 

New Blood Test Promises To Detect Cancer Early

Video taken from the channel: WCCO CBS Minnesota


 

Ovarian cancer screening test shows promise

Video taken from the channel: MD Anderson Cancer Center


 

Does blood test really work for early cancer detection?

Video taken from the channel: CBS Evening News


 

Cancer blood test ‘great step towards early detection of disease’ | ITV News

Video taken from the channel: ITV News


 

Mayo Clinic Minute: Blood-based lung cancer test shows promise

Video taken from the channel: Mayo Clinic


THURSDAY, Jan. 18, 2018 (HealthDay News) In an early step toward “one-stop” screening for cancer, researchers report they’ve developed a blood test that can detect eight types of the disease. THURSDAY, Jan. 18, 2018 (HealthDay News) In an early step toward “one-stop” screening for cancer, researchers report they’ve developed a blood test that can detect eight types of the disease.

The blood test is dubbed CancerSEEK. It was able to catch cancer cases anywhere from 33 percent to 98 percent of the time, depending on the type. THURSDAY, Jan. 18, 2018 In an early step toward “one-stop” screening for cancer, researchers report they’ve developed a blood test that can detect eight types of the disease. The blood test is dubbed CancerSEEK.

It was able to catch cancer cases anywhere from 33 percent to 98 percent of the time, depending on the type. THURSDAY, Jan. 18, 2018 (HealthDay News)—In an early step toward “one-stop” screening for cancer, researchers report they’ve developed a blood test that can detect eight types of the disease.

The blood test is dubbed CancerSEEK. It was able to catch cancer cases anywhere from 33 percent to 98 percent of the time, depending on the type. In an early step toward “one-stop” screening for cancer, researchers report they’ve developed a blood test that can detect eight types of the disease.

The blood test is dubbed CancerSEEK. It was able to catch cancer cases anywhere from 33 percent to 98 percent of the time, depending on the type. THURSDAY, Jan.

18, 2018 (HealthDay News) In an early step toward “one-stop” screening for cancer, researchers report they’ve developed a blood test that can detect eight types of the disease. The blood test is dubbed CancerSEEK. It was able to catch cancer cases anywhere from 33 percent to 98 percent of the time, depending on the type. THURSDAY, Jan. 18, 2018 (HealthDay News) — In an early step toward “one-stop” screening for cancer, researchers report they’ve developed a blood test that can detect eight types of the disease.

The blood test is dubbed CancerSEEK. It was able to catch cancer cases anywhere from 33 percent to 98 percent of the time, depending on the type. Blood test for pancreatic cancer shows promise for early detection. which revealed secreted blood biomarkers of early-stage disease. “Early detection of cancer.

In an early step toward “one-stop” screening for cancer, researchers report they’ve developed a blood test that can detect eight types of the disease. The blood test is dubbed CancerSEEK. It was.

THURSDAY, Jan. 18, 2018 (HealthDay News) — In an early step toward “one-stop” screening for cancer, researchers report they’ve developed a blood test that can detect eight types of the disease. The blood test is dubbed CancerSEEK.

List of related literature:

So while a strong case can be made for cancer screening, there are good reasons to approach it cautiously.

“Overdiagnosed: Making People Sick in the Pursuit of Health” by H. Gilbert Welch, Lisa Schwartz, Steve Woloshin
from Overdiagnosed: Making People Sick in the Pursuit of Health
by H. Gilbert Welch, Lisa Schwartz, Steve Woloshin
Beacon Press, 2011

This approach can also be extended to non-invasive early screening for various other cancer types.

“AACR 2018 Proceedings: Abstracts 3028-5930” by American Association for Cancer Research
from AACR 2018 Proceedings: Abstracts 3028-5930
by American Association for Cancer Research
CTI Meeting Technology, 2018

The recommended frequency of screening is controversial, but the American Cancer Society continues to recommend that it be done annually.

“Clinical Radiation Oncology E-Book” by Leonard L. Gunderson, Joel E. Tepper
from Clinical Radiation Oncology E-Book
by Leonard L. Gunderson, Joel E. Tepper
Elsevier Health Sciences, 2011

Early exciting studies targeting PD1 with antibodies,15 promoting anti-tumor responses in patients with melanoma, kidney cancer, and lung cancer, have been recently reported.

“Clinical Immunology E-Book: Principles and Practice” by Robert R. Rich, Thomas A. Fleisher, William T. Shearer, Harry W. Schroeder Jr., Anthony J. Frew, Cornelia M. Weyand
from Clinical Immunology E-Book: Principles and Practice
by Robert R. Rich, Thomas A. Fleisher, et. al.
Elsevier Health Sciences, 2012

The preliminary biological evaluations against various cancer cell lines are encouraging.

“Green Synthetic Approaches for Biologically Relevant Heterocycles” by Goutam Brahmachari
from Green Synthetic Approaches for Biologically Relevant Heterocycles
by Goutam Brahmachari
Elsevier Science, 2014

This means that the cancer cells have tested negative for estrogen receptors (ERs), progesterone receptors (PRs), and epidermal growth factor receptor 2 (HER2).

“Washington & Leaver’s Principles and Practice of Radiation Therapy E-Book” by Charles M. Washington, Dennis T. Leaver, Megan Trad
from Washington & Leaver’s Principles and Practice of Radiation Therapy E-Book
by Charles M. Washington, Dennis T. Leaver, Megan Trad
Elsevier Health Sciences, 2019

Screening is not effective, because only a small percentage of patients with early stages of cancer show elevated serum SCCA concentrations.

“Tietz Textbook of Clinical Chemistry and Molecular Diagnostics E-Book” by Carl A. Burtis, Edward R. Ashwood, David E. Bruns
from Tietz Textbook of Clinical Chemistry and Molecular Diagnostics E-Book
by Carl A. Burtis, Edward R. Ashwood, David E. Bruns
Elsevier Health Sciences, 2012

If it proves positive it will enable her to receive early treatment for breast cancer and this will improve the outcome for her.

“Psychology for Nurses and the Caring Professions” by Jan Walker
from Psychology for Nurses and the Caring Professions
by Jan Walker
McGraw-Hill/Open University Press, 2012

Screening detects cancers “early,” but this alone cannot justify screening.

“Management of Breast Diseases” by Ismail Jatoi, Manfred Kaufmann
from Management of Breast Diseases
by Ismail Jatoi, Manfred Kaufmann
Springer Berlin Heidelberg, 2010

The test also confirmed that cancer patients are deficient in their ability to reject cancer transplants, with the rejection requiring 6 weeks to several months.

“Hayes' Handbook of Pesticide Toxicology” by Robert Krieger
from Hayes’ Handbook of Pesticide Toxicology
by Robert Krieger
Elsevier Science, 2010

Oktay Kutluk

Kutluk Oktay, MD, FACOG is one of the world's foremost experts in fertility preservation as well as ovarian stimulation and in vitro fertilization for infertility treatments. He developed and performed the world's first ovarian transplantation procedures as well as pioneered new ovarian stimulation protocols for embryo and oocyte freezing for breast and endometrial cancer patients.

Mail: [email protected]
Telephone: +1 (877) 492-3666

Biography: https://medicine.yale.edu/profile/kutluk_oktay/
Bibliography: oktay_bibliography

View all posts

Add comment

Your email address will not be published. Required fields are marked *